Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer seeks Australian OK for GM canola hybrid

Bayer CropScience has applied to the Australian Gene Technology Regulator (OGTR) for the commercial cultivation of genetically modified herbicide-tolerant InVigor x TruFlex Roundup Ready canola. The line has been produced by conventional breeding of the InVigor and TruFlex Roundup Ready lines to provide dual herbicide tolerance and a hybrid breeding system. Bayer plans to conduct demonstration trials and small-scale seed production at selected sites, followed by full commercial release. InVigor (MS8 x RF3) canola is tolerant to glufosinate-ammonium. It was approved for commercial release in 2003. TruFlex Roundup Ready (MON88302) canola is tolerant to higher rates of glyphosate than the first-generation Roundup Ready canola. It was approved in 2014. InVigor x TruFlex Roundup Ready canola has not been grown in Australia but it has been field tested in Chile, Canada and the US. The OGTR expects to issue a risk assessment and management plan in late November 2015.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022588

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel